13 In 1993, The Journal of Clinical Apheresis published a paper detailing the use of TPE as either a first- or second-line therapy to be used with other modalities on disorders such as Raynauds disease, systemic lupus erythematosus, coagulation factor inhibitors, familial hypercholesterolemia, acute Guillain-Barr syndrome, chronic inflammatory demyelinating polyneuropathy, myasthenia gravis, cryoglobulinemia, Goodpastures syndrome, and thrombotic thrombocytopenic purpura
Mechanism of nanoparticle penetration through the BBB The bloodbrain barrier often prevents drugs intended for treating CNS diseases from crossing the BBB, thereby hindering their accumulation and effectiveness in the brain
Andrew Huberman: Well, it's absolutely true
Unseen Threats: The Long-term Impact of PET-Microplastics on Development of Male Reproductive Over a Lifetime
However, thyroid medicines can help prevent problems and are safe to take during pregnancy